{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T07:02:50Z","timestamp":1779692570270,"version":"3.53.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Chronic Thromboembolic Pulmonary Hypertension (CTEPH), classified as group 4 pulmonary hypertension (PH), is a progressive disease caused by unresolved pulmonary artery thrombi that undergo organization and fibrosis, leading to increased pulmonary vascular resistance, right heart failure, and death. Over the past decade, the understanding, diagnosis, and management of CTEPH have undergone profound transformation. This review aims to summarize and discuss recent advances in CTEPH, focusing on pathophysiological mechanisms, diagnostic innovations, therapeutic evolution, and future directions. Current evidence establishes CTEPH as a complex, multifactorial disease involving genetic susceptibility, endothelial dysfunction, inflammation, and aberrant vascular remodeling\u2014far beyond simple mechanical obstruction. In diagnosis, novel imaging modalities including ultra-high-resolution CT, dual-energy CT, computational fluid dynamics, and artificial intelligence have significantly enhanced the sensitivity, objectivity, and functional assessment of pulmonary vascular lesions. Therapeutically, a \u201cthree-pillar\u201d paradigm is now firmly established, with pulmonary endarterectomy (PEA) as the curative cornerstone, complemented by balloon pulmonary angioplasty (BPA) and targeted pharmacotherapy (e.g., riociguat). This paradigm is increasingly evolving toward multimodal combination strategies, including preoperative bridging therapy and management of residual PH after intervention. Despite these advances, critical challenges remain: precise identification of operable patients, optimization of surgical and interventional techniques, development of novel targeted therapies, and construction of individualized prognostic models integrating multiomics and artificial intelligence. By addressing these core issues, this review provides a comprehensive, clinically oriented perspective on the current state and future trajectory of CTEPH research and multidisciplinary management, while also discussing emerging precision medicine approaches (e.g., multi-omics and artificial intelligence) that remain investigational.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1832792","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:05:29Z","timestamp":1779689129000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Research advances in chronic thromboembolic pulmonary hypertension: from pathological mechanisms to multidisciplinary management"],"prefix":"10.3389","volume":"13","author":[{"given":"Juan-Juan","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qian","family":"Huang","sequence":"additional","affiliation":[{"name":"Center of Medical Cosmetology, Chengdu Second People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Kai","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Gansu University of Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Long","family":"Sun","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Gansu University of Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhong","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Geriatric General Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Shaanxi Provincial People's Hospital","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine","place":["Lanzhou, China"]},{"name":"The First Clinical Medical College, Gansu University of Chinese Medicine","place":["Lanzhou, China"]},{"name":"Department of Cardiovascular Medicine, Gansu Provincial People's Hospital","place":["Lanzhou, China"]},{"name":"The First School of Clinical Medicine, Lanzhou University","place":["Lanzhou, China"]},{"name":"Construction Unit of a Branch Center of the National Clinical Research Center for Cardiovascular Diseases","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1801915","DOI":"10.1183\/13993003.01915-2018","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"53","author":"Kim","year":"2019","journal-title":"Eur Respir J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1601792","DOI":"10.1183\/13993003.01792-2016","article-title":"Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature","volume":"49","author":"Ende-Verhaar","year":"2017","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"107177","DOI":"10.1016\/j.rmed.2023.107177","article-title":"Frequency and characterization of CTEPH and CTEPD according to the mPAP threshold > 20\u2005mm hg: retrospective analysis from data of a prospective PE aftercare program","volume":"210","author":"Held","year":"2023","journal-title":"Respir Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.124.068610","article-title":"Worldwide CTEPH registry: long-term outcomes with pulmonary endarterectomy, balloon pulmonary angioplasty, and medical therapy","volume":"150","author":"Delcroix","year":"2024","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3390\/genes16111336","article-title":"Genetic analysis of patients with chronic thromboembolic pulmonary hypertension (CTEPH): a single-center observational study","volume":"16","author":"Bereczky","year":"2025","journal-title":"Genes (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e70231","DOI":"10.1002\/pul2.70231","article-title":"Splenectomy increases CTEPH risk and modifies clinical features of acute pulmonary embolism","volume":"16","author":"White","year":"2026","journal-title":"Pulm Circ"},{"key":"B7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.healun.2025.09.013","article-title":"Endothelin-1 overexpression in pulmonary endarterectomy specimens of CTEPH patients is associated with pulmonary hypertension development","volume":"45","author":"Asghar","year":"2025","journal-title":"J Heart Lung Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3390\/cells10040737","article-title":"The inflammatory profile of CTEPH-derived endothelial cells is a possible driver of disease progression","volume":"10","author":"Smolders","year":"2021","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jacbts.2023.08.005","article-title":"Endothelial overexpression of TGF-\u03b2-induced protein impairs venous thrombus resolution: possible role in CTEPH","volume":"9","author":"Bochenek","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e70664","DOI":"10.14814\/phy2.70664","article-title":"Proximal pulmonary artery wall shear stress derived from computational fluid dynamics: a noninvasive biomarker for CTEPH and perfusion mismatch","volume":"13","author":"Bellouche","year":"2025","journal-title":"Physiol Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1039\/d5lc00300h","article-title":"3D Modelling of pulmonary arterial stenosis and endothelial dysfunction in CTEPH","volume":"25","author":"Nicoleau","year":"2025","journal-title":"Lab Chip"},{"key":"B12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.healun.2022.08.021","article-title":"Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-results from a prospective discovery and validation biomarker study","volume":"42","author":"Hadinnapola","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"B13","doi-asserted-by":"publisher","first-page":"851935","DOI":"10.3389\/fmed.2022.851935","article-title":"Lung ventilation\/perfusion scintigraphy for the screening of chronic thromboembolic pulmonary hypertension (CTEPH): which criteria to use?","volume":"9","author":"Le Pennec","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100344","DOI":"10.1016\/j.jhlto.2025.100344","article-title":"Detectability of subsegmental lesions in patients with inoperable CTEPH: comparison between ultra-high-resolution vs. Conventional CT","volume":"10","author":"Higuchi","year":"2025","journal-title":"JHLT Open"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1055\/a-1502-7541","article-title":"Evaluation of diagnostic accuracy and radiation exposure of dual-energy computed tomography (DECT) in the course of chronic thromboembolic pulmonary hypertension (CTEPH)","volume":"193","author":"Sch\u00fc\u00dfler","year":"2021","journal-title":"Rofo"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.3390\/jcm11175237","article-title":"Correlation between pulmonary artery pressure and vortex duration determined by 4D flow MRI in main pulmonary artery in patients with suspicion of chronic thromboembolic pulmonary hypertension (CTEPH)","volume":"11","author":"Deux","year":"2022","journal-title":"J Clin Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mrm.29965","article-title":"Optimized quantitative mapping of cardiopulmonary oscillations using hyperpolarized 129 Xe gas exchange MRI: digital phantoms and clinical evaluation in CTEPH","volume":"91","author":"Lu","year":"2023","journal-title":"Magn Reson Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e12363","DOI":"10.1002\/pul2.12363","article-title":"(18)F-fluorodeoxyglucose uptake by positron emission tomography in patients with IPAH and CTEPH","volume":"14","author":"Sumer","year":"2024","journal-title":"Pulm Circ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1007\/s00330-025-11678-y","article-title":"Fully automated Bayesian analysis for quantifying the extent and distribution of pulmonary perfusion changes on CT pulmonary angiography in CTEPH","volume":"35","author":"Suchanek","year":"2025","journal-title":"Eur Radiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"185011","DOI":"10.1088\/1361-6560\/ad7455","article-title":"Non-contrasted computed tomography (NCCT) based chronic thromboembolic pulmonary hypertension (CTEPH) automatic diagnosis using cascaded network with multiple instance learning","volume":"69","author":"Zhao","year":"2024","journal-title":"Phys Med Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12880-025-01870-3","article-title":"Machine learning in CTEPH: predicting the efficacy of BPA based on clinical and echocardiographic features","volume":"25","author":"Xi","year":"2025","journal-title":"BMC Med Imaging"},{"key":"B22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10554-023-03026-2","article-title":"Machine learning assisted feature identification and prediction of hemodynamic endpoints using computed tomography in patients with CTEPH","volume":"40","author":"Gawlitza","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3390\/diagnostics15172126","article-title":"Evaluating NT-proBNP-to-albumin (NTAR) and RDW-to-eGFR (RGR) ratios as biomarkers for predicting hospitalization duration and mortality in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)","volume":"15","author":"Iancu","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e42449","DOI":"10.7759\/cureus.42449","article-title":"Relationship between soluble ST2 level and chronic thromboembolic pulmonary hypertension (CTEPH) in acute pulmonary embolism (PE) patients","volume":"15","author":"Kerk\u00fctl\u00fco\u011flu","year":"2023","journal-title":"Cureus"},{"key":"B25","doi-asserted-by":"publisher","first-page":"00356","DOI":"10.1183\/23120541.00356-2020","article-title":"Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH","volume":"6","author":"Kriechbaum","year":"2020","journal-title":"ERJ Open Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.healun.2022.08.017","article-title":"Exercise MR-proANP unmasks latent right heart failure in CTEPH","volume":"41","author":"Kriechbaum","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101751","DOI":"10.1016\/j.ijcha.2025.101751","article-title":"Effects of pulmonary endarterectomy and balloon pulmonary angioplasty in older adults with chronic thromboembolic pulmonary hypertension: a sub-analysis of the CTEPH AC registry","volume":"60","author":"Yamashita","year":"2025","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1055\/s-0041-1740559","article-title":"Does age matter? Pulmonary endarterectomy in the elderly patient with CTEPH","volume":"70","author":"Wiedenroth","year":"2022","journal-title":"Thorac Cardiovasc Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.hlc.2024.06.049","article-title":"Unilateral chronic thromboembolic pulmonary disease: do patients benefit from thromboendarterectomy? Case series from three CTEPH centres","volume":"33","author":"Rashidi","year":"2024","journal-title":"Heart Lung Circ"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s12055-025-02046-y","article-title":"The expanding role of intraoperative transesophageal echocardiography in pulmonary endarterectomy for CTEPH","volume":"41","author":"Mital","year":"2025","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.jhlto.2025.100253","article-title":"Fluid management of cardiopulmonary bypass during pulmonary endarterectomy for CTEPH patients impacts perioperative outcome","volume":"9","author":"Furrer","year":"2025","journal-title":"JHLT Open"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0317826","DOI":"10.1371\/journal.pone.0317826","article-title":"The value of vector ECG in predicting residual pulmonary hypertension in CTEPH patients after pulmonary endarterectomy","volume":"20","author":"Luijten","year":"2025","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0043-1772770","article-title":"Patient-Reported long-term outcome of balloon pulmonary angioplasty for inoperable CTEPH","volume":"73","author":"Wiedenroth","year":"2023","journal-title":"Thorac Cardiovasc Surg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e014785","DOI":"10.1161\/CIRCINTERVENTIONS.124.014785","article-title":"Effect of balloon pulmonary angioplasty and riociguat on right ventricular afterload and function in CTEPH: insights from the RACE trial","volume":"18","author":"Gerges","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"key":"B35","doi-asserted-by":"publisher","first-page":"20042","DOI":"10.1038\/s41598-021-99658-2","article-title":"Depiction of mosaic perfusion in chronic thromboembolic pulmonary hypertension (CTEPH) on C-arm computed tomography compared to computed tomography pulmonary angiogram (CTPA)","volume":"11","author":"Maschke","year":"2021","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1001518","DOI":"10.3389\/fcvm.2022.1001518","article-title":"Balloon pulmonary angioplasty can be an effective and safe therapeutic option in non-surgical elderly patients","volume":"9","author":"Vel\u00e1zquez Mart\u00edn","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cjca.2025.04.029","article-title":"Efficacy and long-term mortality after balloon pulmonary angioplasty in older patients with chronic thromboembolic pulmonary hypertension","volume":"41","author":"Shinya","year":"2025","journal-title":"Can J Cardiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.chest.2025.10.017","article-title":"Impact of elevated pulmonary arterial wedge pressure on safety and efficacy of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension","volume":"169","author":"Szwed","year":"2025","journal-title":"Chest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"100769","DOI":"10.1016\/j.clinsp.2025.100769","article-title":"Riociguat for CTEPH: a retrospective cohort study from a single reference center in Brazil","volume":"80","author":"Fernandes","year":"2025","journal-title":"Clinics (Sao Paulo)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/jcm11041084","article-title":"Riociguat in patients with CTEPH and advanced age and\/or comorbidities","volume":"11","author":"Barnikel","year":"2022","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"00082","DOI":"10.1183\/23120541.00082-2021","article-title":"Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study","volume":"7","author":"Yang","year":"2021","journal-title":"ERJ Open Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12890-025-04069-y","article-title":"Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study","volume":"26","author":"Kam","year":"2026","journal-title":"BMC Pulm Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2400193","DOI":"10.1183\/13993003.00193-2024","article-title":"Efficacy and safety of selexipag in patients with inoperable or persistent\/recurrent CTEPH (SELECT randomised trial)","volume":"64","author":"Kim","year":"2024","journal-title":"Eur Respir J"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/pul2.70001","article-title":"Prostacyclin pathway vasodilators in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a systemic review and meta-analysis of randomized controlled trials","volume":"14","author":"Li","year":"2024","journal-title":"Pulm Circ"},{"key":"B45","doi-asserted-by":"publisher","first-page":"101240","DOI":"10.1016\/j.blre.2024.101240","article-title":"Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH","volume":"68","author":"Escal","year":"2024","journal-title":"Blood Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e12406","DOI":"10.1002\/pul2.12406","article-title":"Treatment and management of chronic thromboembolic pulmonary hypertension (CTEPH): a global cross-sectional scientific survey (CLARITY)","volume":"14","author":"Skoro-Sajer","year":"2024","journal-title":"Pulm Circ"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e12440","DOI":"10.1002\/pul2.12440","article-title":"Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)","volume":"15","author":"Pentik\u00e4inen","year":"2025","journal-title":"Pulm Circ"},{"key":"B48","doi-asserted-by":"publisher","first-page":"110111","DOI":"10.1016\/j.ejrad.2021.110111","article-title":"Effects of BPA on right ventricular mechanical dysfunction in patients with inoperable CTEPH - A cardiac magnetic resonance study","volume":"147","author":"Roller","year":"2022","journal-title":"Eur J Radiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.jhlto.2025.100223","article-title":"Similar quality of life after balloon pulmonary angioplasty or pulmonary endarterectomy for CTEPH","volume":"8","author":"Smeele","year":"2025","journal-title":"JHLT Open"},{"key":"B50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s41687-021-00327-9","article-title":"Symptoms, impacts, and suitability of the pulmonary arterial hypertension - symptoms and impact (PAH-SYMPACT\u2122) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study","volume":"5","author":"Currie","year":"2021","journal-title":"J Patient Rep Outcomes"},{"key":"B51","doi-asserted-by":"publisher","first-page":"101534","DOI":"10.1016\/j.ijcha.2024.101534","article-title":"Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland","volume":"55","author":"Pentik\u00e4inen","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e0260483","DOI":"10.1371\/journal.pone.0260483","article-title":"Hospital costs of balloon pulmonary angioplasty (BPA) procedure and management for CTEPH patients: an observational study based on the French national hospital discharge database (PMSI)","volume":"16","author":"Cottin","year":"2021","journal-title":"PLoS One"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1832792\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T06:05:31Z","timestamp":1779689131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1832792\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":52,"alternative-id":["10.3389\/fcvm.2026.1832792"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1832792","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"article-number":"1832792"}}